Suraksha Diagnostic Limited (NSE:SURAKSHA)
325.80
+20.65 (6.77%)
Aug 21, 2026, 3:29 PM IST
Suraksha Diagnostic Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,968 | 11,872 | 13,499 | - | - | - | |
Market Cap Growth | 3.64% | -12.06% | - | - | - | - |
Enterprise Value | 17,994 | 12,603 | 13,781 | - | - | - |
Last Close Price | 325.80 | 227.95 | 259.20 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 47.36 | 36.88 | 42.42 | - | - | - |
Forward PE | 42.31 | 30.70 | 35.88 | - | - | - |
PS Ratio | 5.21 | 3.83 | 5.36 | - | - | - |
PB Ratio | 6.97 | 4.88 | 6.42 | - | - | - |
P/TBV Ratio | 7.13 | 4.99 | 6.45 | - | - | - |
P/FCF Ratio | 117.15 | 81.96 | 63.27 | - | - | - |
P/OCF Ratio | 20.74 | 14.51 | 21.31 | - | - | - |
PEG Ratio | - | 1.12 | 1.24 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.53 | 4.06 | 5.47 | - | - | - |
EV/EBITDA Ratio | 16.77 | 13.15 | 20.59 | - | - | - |
EV/EBIT Ratio | 29.92 | 23.16 | 28.48 | - | - | - |
EV/FCF Ratio | 124.23 | 87.01 | 64.59 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.54 | 0.54 | 0.42 | 0.51 | 0.62 | 0.68 |
Debt / EBITDA Ratio | 1.21 | 1.36 | 1.07 | 1.26 | 2.11 | 1.57 |
Debt / FCF Ratio | - | 9.00 | 4.17 | 6.03 | 3.13 | 2.59 |
Net Debt / Equity Ratio | 0.43 | 0.43 | 0.33 | 0.20 | 0.27 | 0.38 |
Net Debt / EBITDA Ratio | 0.97 | 1.09 | 1.03 | 0.64 | 1.40 | 1.09 |
Net Debt / FCF Ratio | - | 7.18 | 3.22 | 2.36 | 1.35 | 1.42 |
Asset Turnover | - | 0.79 | 0.80 | 0.75 | 0.68 | 1.00 |
Inventory Turnover | - | 4.51 | 5.12 | 5.51 | 5.99 | 13.14 |
Quick Ratio | - | 0.82 | 0.83 | 1.62 | 1.56 | 1.35 |
Current Ratio | - | 1.05 | 1.10 | 1.84 | 1.78 | 1.64 |
Return on Equity (ROE) | - | 13.84% | 15.91% | 13.82% | 4.03% | 15.31% |
Return on Assets (ROA) | - | 8.70% | 9.54% | 8.55% | 3.29% | 9.98% |
Return on Invested Capital (ROIC) | 12.49% | 12.24% | 14.67% | 14.19% | 6.64% | 16.03% |
Return on Capital Employed (ROCE) | - | 14.00% | 16.60% | 15.20% | 6.00% | 15.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.11% | 2.71% | 2.36% | - | - | - |
FCF Yield | 0.85% | 1.22% | 1.58% | - | - | - |
Dividend Yield | 0.15% | 0.22% | - | - | - | - |
Buyback Yield / Dilution | -0.44% | -0.00% | 2.29% | - | - | 0.02% |
Total Shareholder Return | -0.28% | 0.21% | 2.29% | - | - | 0.02% |